APAC CIO Outlook
  • Home
  • CXO Insights
  • CIO Views
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • About us
Apac
  • Admired Tech

    Agile

    AI Healthcare

    Artificial Intelligence

    Augmented Reality

    Aviation

    Big Data

    Blockchain

    Cloud

    Cryptocurrency

    Cyber Security

    Digital Transformation

    Drone

    HPC

    Infrared

    Internet of Things

    Networking

    PropTech

    Remote Work

    Scheduling Software

    Simulation

    Startup

    Storage

    Wireless

  • Banking

    E-Commerce

    Education

    FinTech

    Food and Beverages

    Healthcare

    Insurance

    Legal

    Manufacturing

    Pharma and Life Science

    Retail

    Travel and Hospitality

  • Atlassian

    CISCO

    Microsoft

    Oracle

    Salesforce

    SAP

    ServiceNow

  • Business Intelligence

    CEM

    Cloud-based Planning

    Cognitive

    Compliance

    Contact Center

    Contact Tracing

    Contactless Payments

    Content Management System

    Corporate Finance

    CRM

    Custom Software Development

    Data Center

    Enterprise Architecture

    Enterprise Communications

    Enterprise Contract Management

    ERP

    Field Service

    HR Technology

    IT Service Management

    Managed Services

    Procurement

    Product Management

    RegTech

    Revenue Management

    Sales Tech

Menu
    • Augmented Reality
    • Agile
    • Cognitive
    • Cyber Security
    • Digital Transformation
    • Atlassian
    • E-Commerce
    • Managed Services
    • RegTech
    • CISCO
    • Blockchain
    • IoT
    • MORE
    #

    Apac CIO Outlook Weekly Brief

    ×

    Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Apac CIO Outlook

    Subscribe

    loading

    THANK YOU FOR SUBSCRIBING

    • Home
    • News
    • Healthcare
    Editor's Pick (1 - 4 of 8)
    left
    Technology’s Role in The Care and Quality of Life for The Aged

    Jose A Perez, Chief Information Officer, Hammondcare

    Digital Transformation - The Right Way

    Amit Goel, CIO, Metropolis Healthcare

    The (E-) Doctor Is In: What Trends to Spot in Healthcare Technology Today

    Dickon Smart-Gill, CIO, Bumrungrad International Hospital

    Analytics and AI in Healthcare

    Steven Parrish, CIO, Taranaki District Health Board

    Document Management in the Cloud

    Alex Choy, EVP R&D CIO, Change Healthcare

    China Embracing Connected Health

    Geoff Feakes, Group CIO, Tunstall Healthcare

    How Healthy is Your IT?

    John Sutherland-CIO-Ramsay Health Care

    Enterprise Architecture - An Extremely Valuable Discipline for Great Businesses

    Ken Spangler, SVP & CIO FedEx Ground and FedEx Freight, FedEx Services IT

    right

    Zentalis Pharmaceuticals Secures USD 20 Million in Series A Round of Financing

    By Apac CIO Outlook | Tuesday, June 02, 2020
    Tweet

    The company will use proceeds from the investment round to develop and commercialize three cancer therapies discovered by Zentalis and potential future candidates in China. Anthony Sun, MD, CEO of Zentalis, will serve as CEO of Zentera

    Fremont, CA: Clinical stage biopharmaceutical company, Zentalis Pharmaceuticals, closed a USD 20 million Series A financing of Zentera Therapeutics, a biopharmaceutical company with headquarters in Shanghai, China. Zentalis focuses on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. The funding round was led by Tybourne Capital Management, a global investment manager headquartered in Asia, with participation from OrbiMed Asia, a leading healthcare fund in Asia. Zentalis, through its wholly-owned subsidiaries, remains the majority shareholder of Zentera.

    Top 10 Healthcare Technology Solution Companies - 2020“The launch of Zentera is a key milestone in our global clinical development strategy,” said Dr. Anthony Sun, Chairman and Chief Executive Officer at Zentalis Pharmaceuticals and Chief Executive Officer at Zentera Therapeutics. “As the second-largest pharmaceutical market in the world, establishing a joint venture in China is the first step toward advancing our product candidates on a global scale. Furthermore, we are building a management team in China of seasoned professionals who are passionate about improving cancer treatment. We would like to thank our partners, Tybourne Capital Management and OrbiMed Asia, for supporting our vision to efficiently advance our best-in-class therapies to markets worldwide.”

    The company will use proceeds from the investment round to develop and commercialize three cancer therapies discovered by Zentalis and potential future candidates in China. Anthony Sun, MD, CEO of Zentalis, will serve as CEO of Zentera. “Over the past few years, we have watched Zentalis’ remarkable clinical progress in developing potentially best-in-class candidates for patients with cancer. We are pleased to work with Zentera, as we believe these therapies will greatly benefit patients internationally,” said Bosun Hau, Managing Director and Co-Head of Private Equity at Tybourne Capital Management

    Zentalis’ pipeline candidates that will be developed in China by Zentera include its oral SERD (ZN-c5), WEE1 inhibitor (ZN-c3), and BCL-2 inhibitor (ZN-d5), which address unmet medical needs in large patient populations in both solid and liquid tumors. Additional Zentalis candidates may also be developed in China by Zentera.

    See also: Top Biotech Solution Companies

    tag

    Pharmaceutical

    Biotechnology

    Weekly Brief

    loading
    ON THE DECK

    Retail 2021

    Top Vendors

    Compliance 2021

    Top Vendors

    Previous Next

    I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

    Read Also

    Role of AI in the Retail Sector

    Role of AI in the Retail Sector

    How Can Smart Retail Tech Help In A Post-Covid Retail Environment?

    How Can Smart Retail Tech Help In A Post-Covid Retail Environment?

    How Cognitive Computing Transforms Healthcare?

    How Cognitive Computing Transforms Healthcare?

    How to Establish Effective Cybersecurity Leadership in Post-COVID Era?

    How to Establish Effective Cybersecurity Leadership in Post-COVID Era?

    Disrupted Employees and Cybersecurity Risks

    Disrupted Employees and Cybersecurity Risks

    The Importance of Cognitive Analytics in Business Growth

    The Importance of Cognitive Analytics in Business Growth

    Loading...

    Copyright © 2021 APAC CIOoutlook. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Use and Privacy and Anti Spam Policy 

    |  Sitemap |  Subscribe

    follow on linkedinfollow on twitter follow on rss
    This content is copyright protected

    However, if you would like to share the information in this article, you may use the link below:

    https://www.apacciooutlook.com/news/zentalis-pharmaceuticals-secures-usd-20-million-in-series-a-round-of-financing-nwid-7507.html